November 10, 2021

Geneyx Genomex Closes $6.5M Seed Financing Roun

staff reporter

NEW YORK – Geneyx Genomex said Tuesday that it has closed a seed financing round worth approximately $6.5 million. Capri Ventures and Accenture Ventures led the round.

The firm, which is based in Herzliya, Israel, and Foster City, California, also said that it has joined Accenture Ventures’ Project Spotlight, a program that helps connect software startups with major public companies.

Geneyx, which makes an artificial intelligence-driven genetic data analysis and interpretation platform to improve risk prediction and diagnostic yield, plans to use the funding to support global growth. The firm hopes to help its users achieve 90 percent diagnostic yield within the next two years with its analysis of whole-genome sequencing data.

“The opportunity for better diagnosis and treatments spanning the continuum of health from prediction to prognosis requires more sophisticated tools for collaboration across sectors of the healthcare and biomedical research ecosystem,” Alex Pinchev, managing partner of Capri Ventures, said in a statement. “Geneyx’s AI-based software solutions have the potential to transform healthcare by enhancing diagnostic and prognostic capabilities across patient populations and democratizing biomedical research.”

Additional Articles

News

November 9, 2021

Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics

Marchell Gillis

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.

November 10, 2021

Geneyx Genomex Closes $6.5M Seed Financing Roun

staff reporter

NEW YORK – Geneyx Genomex said Tuesday that it has closed a seed financing round worth approximately $6.5 million. Capri Ventures and Accenture Ventures led the round. The firm, which is based in Herzliya, Israel, and Foster City, California, also said that it has joined Accenture Ventures' Project Spotlight, a program that helps connect software startups with major public companies.

October 10, 2020

Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics

staff reporter

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, will integrate Toldot’s TGex next-generation

April 8, 2020

Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, will integrate Toldot’s TGex next-generation

Previous
Next

November 9, 2021

Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics

Marchell Gillis

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.

November 10, 2021

Geneyx Genomex Closes $6.5M Seed Financing Roun

staff reporter

NEW YORK – Geneyx Genomex said Tuesday that it has closed a seed financing round worth approximately $6.5 million. Capri Ventures and Accenture Ventures led the round. The firm, which is based in Herzliya, Israel, and Foster City, California, also said that it has joined Accenture Ventures' Project Spotlight, a program that helps connect software startups with major public companies.

October 10, 2020

Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics

staff reporter

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, will integrate Toldot’s TGex next-generation

April 8, 2020

Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, will integrate Toldot’s TGex next-generation